Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PV00 | ISIN: CNE100003PG4 | Ticker-Symbol: 17Q1
Frankfurt
06.06.25 | 08:05
1,680 Euro
-2,33 % -0,040
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
PHARMARON BEIJING CO LTD Chart 1 Jahr
5-Tage-Chart
PHARMARON BEIJING CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,6801,78006.06.
1,6801,78006.06.

Aktuelle News zur PHARMARON BEIJING Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiPHARMARON (03759): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE PREVIOUS ANNUAL REPORTS OF THE COMPANY-
29.05.PHARMARON (03759): (UPDATED) FINAL DIVIDEND IN CASH FOR THE YEAR ENDED DECEMBER 31, 20241
29.05.PHARMARON (03759): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS - NOTIFICATION OF PUBLICATION OF CIRCULAR AND NOTICES FOR THE 2024 ...2
29.05.PHARMARON (03759): NOTIFICATION LETTER AND REQUEST FORM TO H SHAREHOLDERS - NOTIFICATION OF PUBLICATION OF CIRCULAR, NOTICES AND PROXY FORMS FOR THE 2024 ...1
PHARMARON BEIJING Aktie jetzt für 0€ handeln
29.05.PHARMARON (03759): FORM OF PROXY FOR THE FIRST H SHARE CLASS MEETING OF 20252
29.05.PHARMARON (03759): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING OF 2024 (APPLICABLE TO H SHAREHOLDERS)1
29.05.PHARMARON (03759): NOTICE OF THE FIRST H SHARE CLASS MEETING OF 20252
29.05.PHARMARON (03759): NOTICE OF THE ANNUAL GENERAL MEETING OF 20241
29.05.PHARMARON (03759): CIRCULAR FOR THE 2024 ANNUAL GENERAL MEETING AND 2025 FIRST H SHARE CLASS MEETING1
12.05.TheraCryf partners with Pharmaron to develop addiction programme4
29.04.PHARMARON (03759): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS - NOTICE OF PUBLICATION OF 2024 ANNUAL REPORT AND 2024 ENVIRONMENTAL, ...-
29.04.PHARMARON (03759): NOTIFICATION LETTER AND REQUEST FORM TO H SHAREHOLDERS - NOTICE OF PUBLICATION OF 2024 ANNUAL REPORT AND 2024 ENVIRONMENTAL, SOCIAL ...-
29.04.PHARMARON (03759): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT1
29.04.PHARMARON (03759): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO RESIGNATION AND CESSATION OF OFFICE OF NON-EXECUTIVE DIRECTOR-
29.04.PHARMARON (03759): 2024 ANNUAL REPORT-
24.04.CN Bio & Pharmaron Partner to Advance Organ-on-a-Chip Drug Discovery2
24.04.CN Bio and Pharmaron Establish Long-Term Strategic Partnership to Develop OOC Technologies on a Global R&D Platform351Partnership to validate and promote the application of CN Bio's PhysioMimix technology, with future opportunities for novel application and assay development CN Bio, a leading provider of Organ-on-a-chip...
► Artikel lesen
11.04.PHARMARON (03759): NOTICE OF BOARD MEETING1
26.03.PHARMARON (03759): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE OF THE BOARD1
26.03.PHARMARON (03759): (1)PROPOSED ADOPTION OF THE 2025 H SHARE AWARD SCHEME; (2)PROPOSED AMENDMENTS TO THE LIMIT OF THE EXISTING H SHARE AWARD SCHEME; (3)PROPOSED ...-
Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1